Since 2007, total spending on the EpiPen in Medicare Part D has grown substantially – doubling between 2014 and 2016


KFF analysis of a five percent sample of Medicare prescription drug event claims from the CMS Chronic Conditions Data Warehouse, 2007-2016.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.